- AU$32.75bn
- AU$32.54bn
- AU$220.54m
- 100
- 2
- 89
- 70
Annual income statement for Pro Medicus, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 68.1 | 94.1 | 127 | 166 | 221 |
| Cost of Revenue | |||||
| Gross Profit | 67.6 | 93.6 | 127 | 166 | 220 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 25.2 | 31 | 41.2 | 49.8 | 57.2 |
| Operating Profit | 42.9 | 63.1 | 86.1 | 116 | 163 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 42.9 | 63.1 | 86.1 | 116 | 163 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 30.9 | 44.4 | 60.6 | 82.8 | 115 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 30.9 | 44.4 | 60.6 | 82.8 | 115 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 30.9 | 44.4 | 60.6 | 82.8 | 115 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.295 | 0.425 | 0.58 | 0.791 | 1.1 |
| Dividends per Share |